搜索到 1000 条关于 s65실시간대출디비상담I_텔레SUPERADMAN ㄴ 的文章

FDA对核酸流感诊断试剂授予首个CLIA豁免资格

2015.01.09 FDA对核酸流感诊断试剂授予首个CLIA豁免资格

1月6日,美国FDA授权了首个豁免资格,许可一款以核酸为基础的诊断检测试剂—Alerei流感A&B用于...,所以Alerei流感A&B试剂可被分销到各种非传统实验室地点,包括医师办公室、急救室、卫生部门诊所及其它卫生保健场所。“今天的决定允许首
【直播预告】昆明市中医医院手术直播

2019.12.16 【直播预告】昆明市中医医院手术直播

1、直播时间2019 年 12 月 21 号 14:002、直播地点昆明市中医医院3、精彩看点「小马 i 计划」年终学术盛宴,八台连续直播,一睹大家巅峰之作。4、主刀医生邵万金 江苏省中医院/南京中医药大学附属医院主任医师、教授美国 Cleveland 医学中心和 Minnesota 大学医院
【CIT2018】徐波:国产生物可降解支架对于冠脉单支病变患者安全有效

2018.03.29 【CIT2018】徐波:国产生物可降解支架对于冠脉单支病变患者安全有效

CIT 2018 上,来自中国医学科学院阜外医院的徐波教授公布了 FUTURE-I 研究的两年随访结果:国产 Firesorb 西罗莫司靶向洗脱生物可吸收血管支架,对于冠脉单支病变患者安全有效。国产 Firesorb 生物可降解支架,是以体内可降解的高分子材料聚左旋乳酸(PLLA)为骨架材料,以聚 D,L- 
AAOS 2016:社交网络能给骨科医生带来什么?

2016.03.04 AAOS 2016:社交网络能给骨科医生带来什么?

本文作者夏冬冬博士,来自上海同济大学附属东方医院脊柱外科,现为美国哈佛医学院 Postdoctor Fellow。图为夏冬冬博士在会议现场美国骨科医师学会 2016 年会(AAOS 2016)推出了一个新颖的会场-「The way I see it」。作为本届大会的特色,该会场往往讨论一些非常具有前瞻性和潮流话的题目
BLOOD:自体干细胞移植后复发经典霍奇金淋巴瘤的治疗

2016.02.14 BLOOD:自体干细胞移植后复发经典霍奇金淋巴瘤的治疗

血液学专家,近期在 BLOOD 杂志系列文章「HOW I TREAT」中以 3 例经典病例为媒介,介绍了自已治疗自体造血干细胞移植(ASCT)后复发 cHL 的经验... 证实为 I 或 II 期、损害局限于未曾放疗过的淋巴结且没有 B 症状。3. 节点抑制剂和免疫调节治疗cHL 的恶性 RS 细胞表达高水平 PD-L1,能与
第 23 期全国关节镜临床手术操作学习班即将开班

2015.11.25 第 23 期全国关节镜临床手术操作学习班即将开班

中国生物医学工程学会在北京举办「第 23 期全国关节镜临床手术操作学习班」。参加学习者将授予国家级 I 类医学继续教育学分。现将有关事项通知如下:一. 课程内容介绍1. 老师讲解示范膝关节镜手术操作要点、技巧、常见技术难点的解决方法,讲解示范关节镜手术的操作步骤、方法和原理。2. 学员现场操练,老师随时指导,解答学员
第 23 期全国关节镜临床手术操作学习班

2015.11.16 第 23 期全国关节镜临床手术操作学习班

中国生物医学工程学会在北京举办「第 23 期全国关节镜临床手术操作学习班」。参加学习者将授予国家级 I 类医学继续教育学分。现将有关事项通知如下: 一、课程内容介绍1、老师讲解示范膝关节镜手术操作要点、技巧、常见技术难点的解决方法,讲解示范关节镜手术的操作步骤、方法和原理。2、学员现场
2016 第十三届天坛全国呼吸内镜介入技术学习班

2016.07.15 2016 第十三届天坛全国呼吸内镜介入技术学习班

第十三届天坛全国呼吸内镜介入技术学习班(2016-03-02-068 国,国家级 I 类 8 分)定于 2016 年 8 月 12 日至 14 日...呼吸内科项目负责人:张杰 教授继教项目编号:2016-03-02-068 国(国家级I 类 8 分)报到时间:2016
胰岛素过敏一例

2012.09.10 胰岛素过敏一例

一般情况:患者,女,58岁。病史:患者于入院前14年,因口干、多饮在外地医院检测空腹血糖13.8mmol/I。诊断为2型糖尿病(T2DM...肿,双侧足背动脉搏动好。辅助检查:随机血糖18.4mmol/I。,尿蛋白1+,尿糖2+,酮体±,HbA。C9.9%。GAD和IAA均
李  彬

2019.03.05 李 彬

心血管内科 I 病区副主任,医学博士,主任医师,教授,硕士生导师,湖北省突出贡献中青年专家,襄阳市「隆中名医」。擅长是冠心病、心力衰竭、高血压、心肌病等疾病的诊治。尤其是冠心病经皮球囊扩张+支架置入术、快速心律失常射频消融手术、起搏器植入术等。
丁香公开课:陆汉魁教授解读分化型甲状腺癌的治疗

2015.12.01 丁香公开课:陆汉魁教授解读分化型甲状腺癌的治疗

近期,在杭州举办的杭州市第一人民医院第三届杭州甲状腺论坛上。上海交大附属第六人民医院核医学科主任陆汉魁教授就「分化型甲状腺癌颈淋巴转移术后选择(131I)治疗及评价」进行了精彩演讲。ccvideo专家简介:

2012.09.19 【免注册费】上海分子流行病学与GWAS会议国际研讨会

        分子流行病学再揭示人类复杂疾病遗传因素及其与环境因素相互作用发挥重要作用,为人类疾病的风险评估、预防和个性化治疗提供依据。全基因组关联分析(GWAS)为全面系统研究复杂疾病的遗传因素掀开了新的一页,为我们了解人类复杂疾病的发病机制提供了更多的线索。科学家已经在肥胖、糖尿病、冠心病、阿尔茨海默、乳腺癌、前列腺癌、肺癌、胃癌等一系列复杂疾病中进行了全基因组关联研究并找到疾病相关的易感基因,我国科学家也在银屑病、精神病和冠心病等方面开展了GWAS研究并取得成效。国家科技部最新公布了“常见重大疾病全基因组关联分析和药物基因组学研究”的863重点项目,吹响了我国大规模开展GWAS研究的号角。为了让更多的相关研究人员,特别是广大研究生了解GWAS的研究原理和方法,学会设计GWAS的研究和分析实验结果,同时在癌症领域分享海内外研究专家们的成功经验,并期待在GWAS方面进行交流合作,复旦大学和美国Van Andel 研究所将于2009年7月12-14日在上海联合举办上海分子流行病学与GWAS国际 研讨会, 期待各位同道免费参加,请有意者及时将回执返回联系邮箱。免注册费(食宿餐饮费用自理)。名额有限,报名从速!时间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆 上海市邯郸路220号,200433
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹 高歌 联系电话: 021-55664495
回执邮箱: GWAS2009@gmail.com
 BackgroundRecent success of genome-wide association studies (GWAS) in the U.S. and Europe has lead to the identification of a large number of genetic variants that are associated with disease risk and progression, including those for cancer and cardiovascular diseases. The discovery of these genetic markers not only improves our understanding of disease etiology, but also contributes significantly to risk prediction, early detection, and targeted treatment of diseases.Although GWAS have been used in Chinese populations to identify Chinese-specific risk-associated genetic variants for several common diseases such as breast cancer and psoriasis, many more GWAS are needed for various diseases. A better understanding of the importance of GWAS and a better knowledge of study design and data analysis of GWAS will further promote broad application of GWAS in China. This symposium which will cover genetic epidemiology and GWAS in China is organized to serve this purpose. We have invited a group of experts in this area from the U.S. and China to share their experience in GWAS, and we hope to foster an environment which will encourage an open discussion among all participants.
Objectives• To better understand the potential applications of GWAS
• To address practical issues in study design, implementation, and data analysis of GWAS
• To promote interaction and collaboration among researchers who are interested in GWAS
• To explore other important studies after GWAS: gene-environment interaction, risk prediction, and functional analyses
• To consider issues and implications related to genomic and personalize medicine
Organizing committeeThe organizing committee consists of four members:
Dr. Jianfeng Xu (Co-Chair)
Dr. Daru Lu (Co-Chair)
Dr. Li Jin (Co-Chair ,Advisor)
Dr. Qingyi Wei (Co-Chair, Advisor)
PresentationsSession I: Genetic epidemiology and GWAS of cancer
• Breast cancer in Chinese populations Xiao-ou Shu
• Genetic association studies of skin cancer Jiali Han
• Genetic variants in the MC1R gene and risk of cutaneous melanoma Qingyi Wei
• Genetic association studies of lung cancer in Chinese populations Daru Lu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao Zhou
• Molecular epidemiology of stomach cancer Weimin YeSession II: Genetic epidemiology and GWAS of other diseases
• Genetic association studies of hypertension in Chinese populations Jiang He
• GWAS of Autoimmune Diseases (Psoriasis, etc.) in Chinese populations Wei Huang
• Molecular epidemiology of diabetes in Chinese populations Weiping Jia
• Molecular genetics study of hypertension in Chinese populations Dingliang Zhu
• Molecular epidemiology of hepatitis, liver cirrhosis and hepatocarcinoma Gangqiao ZhouSession III: Post-GWAS studies
• Genetic structure of Chinese population Li Jin
• High-throughput genotyping for GWAS and fine mapping studies Siqun Lilly Zheng
• Molecular genetics study of neural tube defect Hongyan Wang
• Risk prediction using genetic variants in prostate cancer Jianfeng Xu
• Gene-environmental interaction in smoking related cancer Zuo-Feng Zhang
• Cancer Somatic Genomics Bin TehSession IV: Short presentations by participants and discussion
Registration时  间: 2009年7月12-14日
报到地点: 复旦大学卿云楼宾馆大厅 上海市邯郸路220号 (200433)
会议地点: 复旦大学逸夫楼报告厅
联 系 人: 赵雪莹,高歌 (Shanghai, China);Tamara Adams (U.S.)
联系电话: 21-55664495 (Shanghai, China);336-713-7532 (U.S.)
回执邮箱: GWAS2009@gmail.com (Shanghai, China);tsadams@wfubmc.edu (U.S.)
Invited speakers (alphabetic)• Jiali Han, Ph.D., is an Assistant Professor of Medicine at Harvard Medical School. His major research areas are:
• Genetic epidemiology of skin cancer and breast cancer
• Genome-wide association studies
• Gene-environment interaction• Jiang He, M.D. Ph.D., is a Professor and Chair of Epidemiology, Tulane University School of Public Health., U.S.A. His major research areas are:
• Genetic epidemiology of hypertension
• Gene-nutrition interaction of cardiovascular disease• Wei Huang, Ph.D., is a Professor and Executive Deputy Director of Chinese National Human Genome Center at Shanghai, China. Her major research areas are:
• Genetic susceptibility to autoimmune diseases, cardiovascular diseases and cancer.
• Genome-wide association studies
• Genetic variants and association study• Weiping Jia M.D., is a professor of endocrinology at Shanghai Institute of Diabetes, Shanghai No.6 People’s Hospital, Shanghai Jiaotong University, Her major research area is:
• Molecular endocrinology and diabetes• Li Jin, Ph.D, is a Professor of Genetics and vice President of Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolism diseases
• Genetic markers for population genetics• Daru Lu, Ph.D, is a Professor of Genetics and Vice Dean of School of Life Sciences, Fudan University, China. His major research areas are:
• Genetic and molecular epidemiology of lung cancer and glioma
• Genetics of metabolic disease• Xiao-ou Shu, M.D, Ph,D, is a Professor of Medicine in the Department of Medicine at the Vanderbilt University School of Medicine, U.S.A. Her major research areas are:
• Genetic and lifestyle predictors of cancer and other chronic diseases
• Cohort study methodology
Incorporating biomarkers in risk prediction• Bin Teh, M.D, is a Distinguished Scientific Investigator at Van Andel Institute, U.S.A. His major research areas are:
• Translational cancer research
• Gene expression profiling
• Cancer genome high-throughput sequencing• Hongyan Wang, Ph.D, is a professor of genetics at School of Life sciences, Fudan University, China. Her major research area is:
• Molecular genetics and epidemiology of birth defects (deformity of neural tube, congenital heart disease, etc.)• Qingyi Wei, M.D, Ph.D, is a Professor of Epidemiology at The University of Texas M. D. Anderson Cancer Center, U.S.A. His major research areas are:
• Molecular epidemiology of DNA repair, apoptosis, and skin cancer and head and neck cancer
• Genetic susceptibility to cancer
• DNA repair and apoptosis phenotype markers• Jianfeng Xu, M.D, Dr.PH, is a Professor of Epidemiology and Cancer Biology and Director of the Center for Cancer Genomics at Wake Forest University School of Medicine, U.S.A. His major research areas are:
• Genetic epidemiology of prostate cancer
• Genome-wide association and fine mapping analysis
• Risk prediction using genetic markers and other clinicopathologic variables• Zuo-Feng Zhang, M.D., Ph.D, is a Professor of Epidemiology at UCLA School of Public Health, U.S.A. His major research areas are:
• Molecular epidemiology of smoking-related cancers
• Confirmation studies of SNPs identified in genome-wide association studies in smoking-related cancers
• Gene-environmental interaction between genetic markers and environmental factorsS. Lilly Zheng, M.D, is a Professor of Medicine and Director of the Genotyping Laboratory at Wake Forest University School of Medicine. U.S.A. Her major research areas are:
• High-throughput genotyping and sequencing
• Genetic epidemiology of prostate cancer• Gangqiao Zhou, Ph.D, is a Professor of Medical Genetics and Genomics in National Academy of Military Medical Science. His major research area is:
• molecular and genetics of complex diseases• Dingliang Zhu, M.D, is a professor of cardiology at Shanghai Institute of Hypertension, Shanghai, China. His major research area is:
• Molecular and genetics of cardiovascular diseases• Weimin Ye, Ph.D, is a Professor of Medical Epidemiology at Karolinska Institutet, Sweden. His major research areas are: Etiology of upper gastrointestinal diseases
• Topic of presentation: Molecular epidemiology of stomach cancer
 
微访谈:王振刚教授谈累及五官的风湿病

2013.07.24 微访谈:王振刚教授谈累及五官的风湿病

本期微访谈,丁香园风湿免疫频道特邀北京同仁医院风湿免疫科王振刚主任与广大站友一起探讨“累及五官的风湿病”这一话题。快速提问通道:http://i.dxy.cn/talk/rheumatology风湿免疫病属疑难杂症,因为它病因不明;风湿免疫病很复杂,因为它累及全身各系
2013年美国癌症协会肺癌筛查指南

2013.05.02 2013年美国癌症协会肺癌筛查指南

Findings from the National Cancer Institute’s National Lung Screening Trial established that lung cancer mortality in specific high-risk groups can
Spine J:颈椎椎动脉横突段走行新知见

2015.11.27 Spine J:颈椎椎动脉横突段走行新知见

风险在于易损伤椎动脉,特别是老年人后柱变薄、骨重建所致的椎动脉弯曲、扩张。土耳其近东大学的学者进行了一项回顾性横断面研究,表明 65 岁以上患者 C6 和 C4... A 组 45 岁以下,B 组 45 岁到 65 岁,C 组 65 岁以上。除外椎动脉走行狭窄而松解的病例。评估指标为椎动脉和横突孔面积(图 1),椎动脉/横突孔
Ian N Bruce

2021.05.06 Ian N Bruce

Trust. I am also Director of the NIHR Manchester Biomedical Research Centre...#39;s University Belfast in 1988 and gained my MRCP in 1991. My clinical

2015.07.30 汉堡大学 Uni Hamburg

in northern Germany. As Germany’s third biggest university we offer a diverse course... of excellence in climate research as part of Germany’s Excellence Initiative. KlimaCampus
上一页 1 2 3 ... 46 47 48 49 50 下一页 到第